Emerging Trends Influencing The Growth Of The cann*abis Use Disorder Market: Advanced And Personalized Treatment Options For cann*abis Use Disorder

We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.

How Big Is the cann*abis Use Disorder Market Size Expected to Be by 2034?
The market size for cann*abis use disorder has experienced a robust expansion in the last few years, with projections showing an increase from $1.53 billion in 2024 to $1.66 billion in 2025, boasting a compound annual growth rate (CAGR) of 7.9%. This historic growth trend is primarily due to factors such as the decriminalization and legalization of cann*abis, heightened public understanding of mental health and addiction, escalation in cann*abis-related research and clinical studies, advancements in addiction treatment and behavioral therapy, along with the growing accessibility to treatments through digital health platforms.

In the coming years, the market size for cann*abis use disorder is expected to witness substantial growth. The prediction is that it will expand to $2.22 billion come 2029, with a CAGR of 7.5%. Factors contributing to this increase during the forecast period include the spread of cann*abis legalization and regulation, enhanced understanding and integrated treatment models for mental health, breakthroughs in medicinal treatments and FDA approvals, the emergence of digital therapeutics and telehealth services, and a rising investment in research and treatments grounded in evidence. Upcoming trends anticipated during the forecast span include adoption of digital and mobile health interventions, the emergence of studies indicating psilocybin-assisted therapy, progress in treatment alternatives, the embracing of personalized medicine, and advancements in the field of biotechnology.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21126

What Are the Emerging Segments Within the cann*abis Use Disorder Market?
The cann*abis use disorder market covered in this report is segmented -

1) By Treatment: Pharmacotherapy, Behavioral Therapies
2) By Route Of Administration: Oral, Transdermal, Inhalation, Sublingual
3) By End-User: Hospitals, Specialty Clinics, Rehabilitation Centers, Homecare Settings

Subsegments:
1) By Pharmacotherapy: cannabi*noid-Based Medications, Antidepressants, Antipsychotics, Benzodiazepines
2) By Behavioral Therapies: Cognitive Behavioral Therapy (CBT), Contingency Management, Motivational Enhancement Therapy (MET), 12-Step Facilitation Therapy

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21126&type=smp

What Long-Term Drivers Are Shaping cann*abis Use Disorder Market Trends?
Anticipated growth in the cann*abis use disorder market is linked to the rising consciousness and identification of cann*abis addiction. Public education, physician training, and informing individuals about the indications, manifestations, and risks associated with cann*abis use disorder (CUD) are part of this awareness and diagnosis process. The enhancement in awareness and diagnosis of cann*abis addiction can be attributed to multiple factors, such the rise in cann*abis legalization & accessibility and the expanding recognition by science & medicine. Treatment for cann*abis use disorder focuses on a structured approach that aids in the management of withdrawal symptoms, curbs cravings, and tackles inherent psychological aspects. This directly assists in the diagnosis of cann*abis addiction by offering clinical proof of dependency behaviors, emphasizing the intensity of the disorder, and directing the suitable level of interference based on the individual's distinctive requirements. For example, data from the Office for Health Improvement and Disparities, a UK government department, released in December 2023, indicates a 2% increase this year in the number of people seeking help for cann*abis-related concerns, growing from 28,263 in 2021 to 28,845 in 2022. Hence, the escalation in consciousness and diagnosis of cann*abis addiction is propelling the growth of the cann*abis use disorder market.

Who Are the Top Competitors in Key cann*abis Use Disorder Market Segments?
Major companies operating in the cann*abis use disorder market are Lyra Health Inc., Pyramid HealTH*Care Inc., Hazelden Betty Ford Foundation, Charlie Health, Caron Treatment Center, Promises Behavioral Health, Sierra Tucson, Samarpan, Affect Therapeutics Inc., Cadabam's Rehabilitation Center, Aelis Farma, Skywood Recovery, Pelago, PleoPharma Inc., Abhasa, Marijuana Anonymous, Northpoint Colorado, Sukoon Health, Granite Mountain Behavioral HealTH*Care, GreeneStone

What Are the Latest Developing Trends in the cann*abis Use Disorder Market?
Leading corporations in the cann*abis use disorder market are prioritizing the development of innovative substance use management systems to deliver customized treatment to people grappling with cann*abis dependency. A substance use management system is a comprehensive approach designed to prevent, address, and manage drug use disorders, assisting individuals in defeating their reliance on substances such as cann*abis. The focus is on long-term recovery, the prevention of relapse, and improving overall well-being. For example, in April 2024, Pelago, a virtual clinic in the US committed to addressing substance abuse, launched a treatment regime for cann*abis use disorder. The treatment addresses the escalating cases of cann*abis use disorder in the US, affecting approximately 18 million adults. Pelago's strategy features education around cann*abis use and the introduction of evidence-supported treatments like cognitive behavioral therapy and motivational enhancement therapy. Additionally, the program caters to adolescents aged between 15 and 17 years by focusing on objectives rooted in abstaining.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/cann*abis-use-disorder-global-market-report

Which Regions Are Becoming Hubs for cann*abis Use Disorder Market Innovation?
North America was the largest region in the cann*abis use disorder market in 2024. The regions covered in the cann*abis use disorder market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the cann*abis Use Disorder Market?
2. What is the CAGR expected in the cann*abis Use Disorder Market?
3. What Are the Key Innovations Transforming the cann*abis Use Disorder Industry?
4. Which Region Is Leading the cann*abis Use Disorder Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.